Home » Top Tips » Medical Conditions » Diabetes and Kidneys » Sevelamer – a phosphate binder for kidney bone disease
Andy Stein
May 29, 2026

Sevelamer – a phosphate binder for kidney bone disease

Save article
[favorite_button post_id="" site_id=""]
NHS building external view
This is how the AI article summary could look. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Sevelamer – a phosphate binder for kidney bone disease

Sevelamer - Wikipedia

Sevelamer is a medication used to control phosphate levels, primarily in patients with chronic kidney disease (CKD).

What is sevelamer?

  • Sevelamer is a phosphate binder used to reduce high blood phosphate levels (hyperphosphataemia).

  • It is most primarily used for patients with chronic kidney disease (CKD) who are on dialysis.

  • Unlike some other binders, sevelamer is calcium-free and metal-free, meaning it lowers phosphate without raising calcium or aluminum levels in the body.

  • By keeping phosphate levels in check, it helps protect your bones and reduces the risk of dangerous mineral deposits in your heart and blood vessels.

Note. Advantages: It is often chosen because it does not increase calcium levels (avoiding hypercalcaemia), making it safer for patients who cannot tolerate calcium-based binders – especially if they have had hypercalcaemia.

How it works

The mechanism of action of sevelamer involves ‘binding’ to phosphate in the digestive tract:

  • When taken with meals, sevelamer attaches to the phosphate found in your food.

  • This prevents the phosphate from being absorbed into your bloodstream.

  • Instead, the bound phosphate passes safely through your system and is eliminated in your stool.

Who is sevelamer used for?

The main uses of sevelamer include the treatment of:

  • Hyperphosphataemia (high blood phosphate) in adults with CKD, who are not on dialysis

  • Patients on dialysis (both haemodialysis and peritoneal dialysis).

By controlling phosphate, sevelamer helps prevent secondary hyperparathyroidism and metabolic bone disease.

Dose

  • Adults: The starting dose is usually 800 mg to 1600 mg taken three times a day with meals.

  • Titration: Your doctor will adjust the dose based on your blood phosphate levels.

  • Available as sevelamer carbonate (Renvela) or sevelamer hydrochloride (Renagel).

Note: Sevelamer must be taken with food to be effective. Tablets should be swallowed whole; do not crush, chew, or break them.

Side-effects

Most sevelamer side-effects are gastrointestinal, as the medicine stays within the digestive tract.

  • Nausea and vomiting

  • Diarrhea or constipation

  • Indigestion or stomach pain

  • Bloating and gas

Serious symptoms to report:

  • Severe constipation or worsening ‘blockage’ feelings.

  • Difficulty swallowing.

  • Severe abdominal pain.

Monitoring

Your doctor should monitor:

  • Blood Phosphate: To ensure the dose is effectively binding the phosphate from your diet.

  • Blood Calcium and Bicarbonate: To maintain a healthy mineral balance.

  • Vitamins: Because it binds substances in the gut, sevelamer can sometimes lower the absorption of vitamins D, E, K, and folic acid.

Related Posts

Share this article

Your feedback matters to us!

Comments

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    myHSN is here to help you get the best you can out of the NHS.

    Full of top tips and advice from health care professionals on how the NHS works and how you can make sure it works for you.
    Copyright © 2025 Health Service Navigator